This article has been updated to clarify CMS's initial determination on the reimbursement process for AMA's new molecular pathology test codes.

NEW YORK (GenomeWeb News) – The Centers for Medicare & Medicaid Services last week issued a preliminary decision to place new Current Procedural Terminology codes for molecular diagnostics that it determines fall under its clinical laboratory fee schedule to be reimbursed via the so-called "gapfill" process.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

CNBC reports that Amazon invested in the startup Grail as it sees an opportunity for its cloud computing company in genomics.

Lawrence Krauss writes at Slate that science is needed for good public policy and should not be ignored.

Researchers are working on re-making the yeast genome from scratch, according to the Associated Press.

In Cell this week: functional profiling of Plasmodium genome, a self-inactivating rabies virus, and more.